FDA Investigator Lindsey M Schwierjohann

Lindsey M Schwierjohann has inspections in 7 countries as of 27 Oct 2023. Lindsey M Schwierjohann has collaborated with a combinined 5491 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
203
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, China, Italy, Japan, Belgium, Taiwan, Austria
Co-Investigator(s):
Ademola O Daramola, Alan Escalona, Alan M Barker, Alec M O'neal, Allison C Hunter, Allison E Sincek, Allison M Scheck, Amanda M Dunneback, Andrew I Carr, Andrew J Barrowcliff, Andrew M Kupper, Andria L Kuhlman, Angela E Glenn, Anissa C Kelley, Anna M Brannen, Arie R Dyk, Arsen Karapetyan, Azza Talaat, Bailey A Uetrecht, Benjamin D Motsinger, Benjamin D Shuler, Bethany L Subel, Blyss L Ketterer, Brenda C Hamilton, Brigitte K Hofmann, Bryan J Love, Burnell M Henry, Byeongtaek Oh, Caitlin L Almonrode, Carlos Hruiz Nunez, Cassandra L Abellard, Cassandra L Winters, Charisse K Green, Charles I Ann, Charles L Zhou, Charles M Edwards, Chelsea J Falkowski, Cherrie A Zachary, Chris B Dedic, RS, Christian L Witkovskie, Christina Capacci Daniel, PhD, Christina L Bigham, Christine E Kelley, Christopher T Middendorf, Concepcion Cruz, Jr, Constantin Y Philopoulos, Courtney E Hillier, Craig P Seaborn, Craig T Rybus, Cynthia M Goudeau, Cynthia T Cain, D Yvette Barnett, Daisy E Ramos, Darren S Morgan, David P Moorhead, David S Jackson, Dell S Moller, Denise M Digiulio, Diane R Mcdaniel, Donald W Myrick, Dongping Dai, PhD, Donna F Campbell, Dorathy M Eischen, Doretha M Tonkins, Dr. Gang Wang, PhD, Dr. Jason R Caballero, Dyvette Arline, Edwin Melendez, Elisa A Nickum, Elisa A Weckerling, Elizabeth L Loreaux, Elizabeth Ll Edwards, Elizabeth P Kinsella, Emest F Bizjak, Emily J Orban, Emma A Nesbit, Felipe Rde Almeida, Felix Maldonado, Frank W Perrella, Frederick M Lochner, Gam S Zamil, Genevieve E Ghand, Geoffrey K Kilili, George J Flynn, Gerard T Schneider, Gina M Brackett, Green, Gretchen N Kilby, Hang N Guo, Heather A Mccauley, Helen Verdel, Holly J Wilson, Hugh M Mcclure, II, Isabel Y Espinosa, Israel Santiago, OCM, Ivis Lnegron Torres, James C Maclaughlin, James G Marsh, James Norman, Jamie L Dion, Janet L Bowen, Jason D Werne, Jason G Marsh, Jason R Vidaurrie, Javier O Vega, Javonica F Penn, Jazmine N Still, Jeffrey A Sincek, Jennifer A Pruden, Jennifer L Gustavus, Jennifer L Jager, Jennifer L Sheehan, Jennifer L Watson, Jennifer Lalama, Jennifer M Heitz, Jeremiah D Beckwith, Jerry J Corwin, Jessica L Pressley, Jessica M Wooten, Jill J Tillman, Jill R Loeliger, Jill R Raezer, John D Jaworski, John E Russell, Jon P Antoniou, Jonathan A Ferguson, Jonathan W Chapman, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose Martinez, Jr, Jose O Hernandez, Jose R Hernandez, Joseph X Kaufman, Joshua P Wireman, Joshua S Hunt, Joshua Wireman, Justin A Boyd, Karen M Cooper, Katherine E Jacobitz, Katherine Szestypalow, Kathleen D Culver, Kathleen Dant Ceckner, Kathryn J Mccarty, Katie L Korchinski, Keith J Mason, Kelley L Clark, Kellia N Hicks, Kenneth E Felkley, Kenneth H Williams, Kham Phommachanh, Kimberly A Joseph, Kirk W Gaston, Klein, Krista S Tuggle, Krista T Ferry, Kumar G Janoria, Laureen M Geniusz, Lauren N Howard, Lauren N Smith, Lauren R Collins, Laurie Nelson, Laurimer Kuilan Torres, Leena Thomas, Lequita M Mayhew, Leslie A Paul, Lianji Jin, Lindsey M Schwierjobann, Lindsey M Schwierjohan, Lindsey S Fleischman, Lisa R Hilliar, Logan T Williams, Lori A Carr, Lori A Lahmann, Luckner Jean Marie, Luis A Dasta, Lynnsey A Renn, Malik S Qaiser, Maney P Sturgill, Mantai Z Mesmer, Marcellinus D Dordunoo, Marcus A Ray, Maressa L Mills, Marianne Allen, Maribeth G Grattan, Maribeth G Niesen, Marie F Morin, Marijo B Kambere, PhD, Marissa R Stough, Mark E Parmon, Martha Sullivan Myricj, Martha Sullivan Myrick, Mary B Sheets, Mary E Storch, Matt D Suedkamp, Matthew B Casale, Matthew D Soedkamp, Matthew H Pitts, Maureen F Alleman, Meredith M Cobb, Michael D Thatcher, Michael E Campbell, Michael E Clark, Michael J Schibi, Michael K Larson, Michael L Casner, Michael P Sheehan, Michael R Goga, Micheal F Clark, Michele L Obert, Minh D Phan, Moseley Fulcher, Mra Mcculloughj, Mra Munizn, Muna Algharibeh, Nadeem I Chaudhry, Nancy Haggard, Nancy L Neiger, Nibin Varghese, MS, Nicholas J Presto, Nicholas L Paulin, Nina Ni, Nisha C Patel, Noreen Muniz, Pamela A Kuist, Paranthaman Senthamaraikannan, Parul M Patel, Patrick C Klotzbuecher, Patty P Kaewussdangkul, Peter E Baker, Philip F Istafanos, DMV, MS, Philip S Woodward, Phillip M Pontikos, Pifer, Rafeeq A Habeeb, Ramon A Hernandez, Raquel L Coleman, Rebecca Rodriguez, Renee N Easter, Richard T Riggie, Richard W Berning, Richmond K Yip, Robbie J Alleman, Robert D Tollefsen, Robert J Martin, Robert P Neligan, Robert Rodriguez, Robert W Hudson, Rohn R Robertson, Rosanna M Goodrich, Rose Xu, Roy C Stephens, Saleem A Akhtar, Samuel A Hamblin, Sangeeta M Khurana, PhD, Santos E Camara, Sarah E Rhoades, Satheesh Thomas, Shannon A Gregory, Shannon D Fink, Shannon F Underwood, Shirley J Berryman, Sina Shojaee, Siobhan G Taylor, Sixto M Mercado Rios, State Agency, Stephanie A Slater, MS, Stephen J Kilker, Stephen J Rabe, Steven P Eastham, Susan M Taylor, Susan W Ting, Sydney S Choi, Taichun Qin, PhD, Talmane J Fisher, Tamara M Kays, Tarun D Mehta, Teresa I Navas, Teresa K Kastner, Theresa C Klaman, Theresa Kirkham (NMI), Thomas B Smith, Thomas C Woods, Thomas J Arista, Thomas J Prigge, Thomas W Nojek, Thunder N Dunkijacobs, Tiara Nbrown Crosen, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Harris, Troy A Huffman, Ucheabuchi C Chudi Nwankwor, Uduak M Inokon, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vlada Matusovsky, Walden H Lee, Wen Ning Chan (Sally), Wendy G Tan, PhD, William A Warnick, William J Leonard, Ying Zhang, Yumi J Hiramine, Yvette Mlacour Davis, Yvins Dezan, Zachary A Bogorad

Lindsey M Schwierjohann's Documents

Publish Date Document Type Title
March, 2011 FDA 483 Anthony Grote - Form 483, 2011-03-30
June, 2018 FDA 483 Sumika Chemical Analysis Service, Ltd. - Form 483, 2018-06-22
February, 2018 EIR Patheon Pharmaceuticals Inc. - EIR, 2018-02-14
January, 2018 EIR Teva Women's Health LLC - EIR, 2018-01-26
August, 2015 FDA 483 Response GenPak Solutions LLC - Form 483R, 2015-08-27
December, 2014 FDA 483 ICROM SRL - Form 483, 2014-12-05
December, 2015 FDA 483 Camco Chemicals Company Inc - Form 483, 2015-12-09
June, 2018 FDA 483 Central Glass CO., LTD. - Form 483, 2018-06-29
October, 2015 EIR Best Sanitizers, Inc - EIR, 2015-10-16
May, 2013 FDA 483 GenPak Solutions LLC - Form 483, 2013-05-10
October, 2019 FDA 483 Response L. Perrigo Company - Form 483R, 2019-11-07
January, 2018 FDA 483 Neogen Corporation - Mercer Rd. - Form 483, 2018-01-11
April, 2014 FDA 483 American Regent, Inc. - Form 483, 2014-04-04
June, 2010 EIR J.M. Smucker LLC - EIR, 2010-06-24
September, 2016 FDA 483 Bushu Pharmaceuticals, Ltd. - Form 483, 2016-09-16
October, 2019 EIR L. Perrigo Company - EIR, 2019-10-22
October, 2015 FDA 483 Best Sanitizers, Inc - Form 483, 2015-10-16
October, 2017 FDA 483 Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd. - Form 483, 2017-10-20
February, 2018 FDA 483 Patheon Pharmaceuticals Inc. - Form 483, 2018-02-14
March, 2018 FDA 483 Resilience US, Inc. - Form 483, 2018-03-08
June, 2016 FDA 483 Safecor Health, LLC - Form 483, 2016-06-30
June, 2011 FDA 483 RPh Concepts LLC - Form 483, 2011-06-23
August, 2013 FDA 483 Patheon Pharmaceuticals Inc. - Form 483, 2013-08-26
October, 2012 FDA 483 KUTOL PRODUCTS COMPANY - Form 483, 2012-10-11
August, 2015 EIR Patheon Pharmaceuticals Inc. - EIR, 2015-08-21
January, 2014 FDA 483 KUTOL PRODUCTS COMPANY - Form 483, 2014-01-02
August, 2017 FDA 483 RXQ Compounding LLC - Form 483, 2017-08-08
August, 2015 FDA 483 Patheon Pharmaceuticals Inc. - Form 483, 2015-08-21
January, 2018 FDA 483 Teva Women's Health LLC - Form 483, 2018-01-26
January, 2018 EIR Neogen Corporation - Mercer Rd. - EIR, 2018-01-11
September, 2016 EIR Bushu Pharmaceuticals, Ltd. - EIR, 2016-09-16
April, 2016 EIR Medivet America LLC - EIR, 2016-04-08
September, 2016 FDA 483 Sumitomo Chemical Company, Limited - Form 483, 2016-09-23
February, 2018 FDA 483 Response Patheon Pharmaceuticals Inc. - Form 483R, 2018-03-08
January, 2016 FDA 483 Shandong Lukang Pharmaceutical Co., Ltd. - Form 483, 2016-01-15
September, 2017 FDA 483 Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site) - Form 483, 2017-09-20
August, 2015 FDA 483 GenPak Solutions LLC - Form 483, 2015-08-12
January, 2016 FDA 483 Hainan Shuangcheng Pharmaceuticals Co., Ltd. - Form 483, 2016-01-28
September, 2015 EIR Allergan Sales, LLC - EIR, 2015-09-22
March, 2018 EIR Resilience US, Inc. - EIR, 2018-03-08
February, 2017 FDA 483 Changzhou Jintan Qianyao Pharmaceutical Raw Materials - Form 483, 2017-02-17
May, 2017 FDA 483 Nutrishare Inc - Form 483, 2017-05-26
January, 2013 EIR Synergy Health AST LLC - EIR, 2013-01-23
November, 2014 FDA 483 Golden Touch, llc - Form 483, 2014-11-05
October, 2019 FDA 483 L. Perrigo Company - Form 483, 2019-10-22
March, 2016 FDA 483 Guang'an Kingday Pharma & Chem Co., Ltd - Form 483, 2016-03-04
February, 2011 EIR Pure Oxygen Services LLC - EIR, 2011-02-10
October, 2016 EIR Xellia Pharmaceuticals USA LLC - EIR, 2016-10-13
August, 2016 EIR Resilience US, Inc. - EIR, 2016-08-24
February, 2019 FDA 483 Patheon Pharmaceuticals Inc. - Form 483, 2019-02-15
January, 2017 FDA 483 Zhejiang Hisun Pharmaceutical Co., Ltd. - Form 483, 2017-01-19
April, 2015 FDA 483 Yantai Dongcheng Biochemicals Co.,Ltd. - Form 483, 2015-04-17
January, 2017 FDA 483 Tai Heng Industry Co., Ltd. - Form 483, 2017-01-13
May, 2013 EIR GenPak Solutions LLC - EIR, 2013-05-10
December, 2016 FDA 483 Basic Drugs Inc. dba Basic Vitamins - Form 483, 2016-12-08
February, 2019 EIR Patheon Pharmaceuticals Inc. - EIR, 2019-02-15
June, 2017 EIR Resilience US, Inc. - EIR, 2017-06-27
October, 2016 FDA 483 Smithfield BioScience, Inc. - Form 483, 2016-10-27

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more